ÂÜÀòÂÒÂ×

Jean-Philippe Combal is a seasoned professional in the pharmaceutical and biotechnology sectors, currently serving as Co-Founder and Chief Executive Officer of Vivet Therapeutics since March 2017, focusing on innovative gene therapy treatments for orphan diseases. In addition, Jean-Philippe serves as Chairman of the Board of Directors at Splice Bio, a company utilizing advanced technology to enhance gene therapy delivery. Previous roles include Chief Operating Officer at GenSight Biologics, Strategic Therapeutic Area Leader at Galderma International, and various leadership positions in development and marketing at companies such as Fovea Pharmaceuticals and Pierre Fabre Medicament. Jean-Philippe's educational background includes degrees from INSEAD, ESCP Business School, CEDEP, and Paris-Sud University.